ID
33151
Beschrijving
Study ID: 107806 Clinical Study ID: RA3107806 Study Title: An open label study to determine the safety, tolerability, excretion balance and pharmacokinetics of Losmapimod, administered as a single dose of an oral solution to healthy adult male subjects Patient Level Data: Clinicaltrials.gov Identifier: NCT00599612 https://clinicaltrials.gov/ct2/show/NCT00599612 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: losmapimod Trade Name: losmapimod Study Indication: Pulmonary Disease, Chronic Obstructive The study consists of a screening, study visit and follow-up. The protocol identifier for all: RA3107806 This document contains Vital signs . It has to be filled in for study visit.
Link
https://clinicaltrials.gov/ct2/show/NCT00599612
Trefwoorden
Versies (1)
- 29-11-18 29-11-18 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
29 november 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Safety, tolerability, excretion balance and pharmacokinetics of Losmapimod in healthy males, NCT00599612
Similar models
Vital signs
- StudyEvent: ODM
C0038846 (UMLS CUI [1,2])
C0038846 (UMLS CUI [1,2])